Search
Browse
Statistics
Feeds

Anticholinergic burden in the German National Cohort (NAKO): patterns of anticholinergic drug exposure and utilization

[thumbnail of Publisher's Version]
Preview
PDF (Publisher's Version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
857kB
[thumbnail of Supplementary Data] MS Word (Supplementary Data)
4MB

Item Type:Article
Title:Anticholinergic burden in the German National Cohort (NAKO): patterns of anticholinergic drug exposure and utilization
Creators: Könnecke, Julie K., Bößneck, Nele L., Drebka, Alexandra, Scholl, Annika J., Degen, Miriam, Ebert, Nina, Heier, Margit, Keil, Thomas, Leitzmann, Michael, Mikolajczyk, Rafael, Moreno Velásquez, Ilais, Obi, Nadia, Pendt, Phil, Pischon, Tobias ORCID logoORCID: https://orcid.org/0000-0003-1568-767X, Sallam, Nahlah, Schöttker, Ben, Woeckel, Margarethe and Bachmeier, Beatrice E.
Abstract:BACKGROUND: Medication-related anticholinergic burden (AB) has been studied mainly in older adults and selected patient populations, whereas population-based evidence across adulthood remains limited, particularly regarding over-the-counter (OTC) drug use and utilization patterns. OBJECTIVE: To characterize the frequency, distribution, and pharmacological drivers of AB in the German National Cohort (NAKO). METHODS: We conducted a cross-sectional analysis of NAKO baseline data collected in 2014–2019 from participants aged 19–75 years recruited through age- and sex-stratified random sampling from population registries. AB was quantified from participant-reported seven-day medication use using the German Anticholinergic Burden Scale; cumulative scores ≥ 1 and ≥ 3 defined any and high burden, respectively. Descriptive analyses characterized AB by age, sex, drug class, prescription status, and utilization pattern; logistic regression assessed associations of AB with age, sex, and polypharmacy. RESULTS: Among 199,813 participants (median age 51 years; 50.4% women), 17.4% had any and 3.0% had high AB, with exposure in all analyzed age groups. Any and high AB were associated with female sex (aOR = 1.09, 95% CI 1.06–1.12 and aOR = 1.44, 95% CI 1.37–1.53, respectively), most older age groups, and polypharmacy. Nervous system drugs contributed most to aggregate AB. Medications obtained OTC accounted for over one tenth of the sample's burden, with a greater relative contribution in younger age groups. Most anticholinergic drugs were used on a scheduled basis, with daily and long-term use predominating. CONCLUSION: In this large population-based cohort, anticholinergic exposure was observed across all examined age groups, and OTC medications made a non-negligible contribution to the overall burden. These findings suggest that age range and non-prescription medication use may be important considerations when assessing AB.
Keywords:Anticholinergic Burden, Pharmacoepidemiology, Polypharmacy, Over-the-Counter Medication, German National Cohort
Source:Exploratory Research in Clinical and Social Pharmacy
ISSN:2667-2766
Publisher:Elsevier
Volume:24
Page Range:100869
Number of Pages:1
Date:December 2026
Official Publication:https://doi.org/10.1016/j.rcsop.2026.100869
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library